Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
131.2 USD | +0.37% | +4.31% | +20.34% |
Apr. 26 | Wolfe Research Adjusts Price Target on Merck & Company to $151 From $141 | MT |
Apr. 26 | Morgan Stanley Adjusts Merck & Co.'s Price Target to $132 From $128 | MT |
MarketScreener Strategies
Merck and Company : Leader in oncology, modest valuation | October 29, 2019 at 11:04 am EDT |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- MarketScreener Strategies